<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD03290000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>Q96SB4</UniProt_ID>
  <Seq_Length>655</Seq_Length>
  <Molecule_Weight>74325</Molecule_Weight>
  <KEGG_ID>hsa:6732</KEGG_ID>
  <Orthology_ID>K15409</Orthology_ID>
  <EBI_ID>EBI-539478</EBI_ID>
  <Function_Summary>Serine/arginine-rich protein-specific kinase which specifically phosphorylates its substrates at serine residues located in regions rich in arginine/serine dipeptides, known as RS domains and is involved in the phosphorylation of SR splicing factors and the regulation of splicing. Plays a central role in the regulatory network for splicing, controlling the intranuclear distribution of splicing factors in interphase cells and the reorganization of nuclear speckles during mitosis. Can influence additional steps of mRNA maturation, as well as other cellular activities, such as chromatin reorganization in somatic and sperm cells and cell cycle progression. Isoform 2 phosphorylates SFRS2, ZRSR2, LBR and PRM1. Isoform 2 phosphorylates SRSF1 using a directional (C-terminal to N-terminal) and a dual-track mechanism incorporating both processive phosphorylation (in which the kinase stays attached to the substrate after each round of phosphorylation) and distributive phosphorylation steps (in which the kinase and substrate dissociate after each phosphorylation event). The RS domain of SRSF1 binds first to a docking groove in the large lobe of the kinase domain of SRPK1. This induces certain structural changes in SRPK1 and/or RRM2 domain of SRSF1, allowing RRM2 to bind the kinase and initiate phosphorylation. The cycles continue for several phosphorylation steps in a processive manner (steps 1-8) until the last few phosphorylation steps (approximately steps 9-12). During that time, a mechanical stress induces the unfolding of the beta-4 motif in RRM2, which then docks at the docking groove of SRPK1. This also signals RRM2 to begin to dissociate, which facilitates SRSF1 dissociation after phosphorylation is completed. Isoform 2 can mediate hepatitis B virus (HBV) core protein phosphorylation. It plays a negative role in the regulation of HBV replication through a mechanism not involving the phosphorylation of the core protein but by reducing the packaging efficiency of the pregenomic RNA (pgRNA) without affecting the formation of the viral core particles. Isoform 1 and isoform 2 can induce splicing of exon 10 in MAPT/TAU. The ratio of isoform 1/isoform 2 plays a decisive role in determining cell fate in K562 leukaemic cell line: isoform 2 favors proliferation where as isoform 1 favors differentiation.</Function_Summary>
  <Catalytic_Mechanism>ATP + a protein = ADP + a phosphoprotein.</Catalytic_Mechanism>
  <Pfam_ID>PF00069:Pkinase</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>0</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Serine/arginine-rich protein-specific kinase 1</Alias>
      <Alias>SR protein kinase 1</Alias>
      <Alias>SFRS protein kinase 1</Alias>
      <Alias>SR-protein-specific kinase 1</Alias>
      <Alias>SRPK1</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).</Detail>
      <Keyword>Protein binding</Keyword>
      <Ontology_ID>GO:0005515</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with magnesium (Mg) ions.</Detail>
      <Keyword>Magnesium ion binding</Keyword>
      <Ontology_ID>GO:0000287</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose.</Detail>
      <Keyword>Nucleotide binding</Keyword>
      <Ontology_ID>GO:0000166</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the transfer of a group, e.g. a methyl group, glycosyl group, acyl group, phosphorus-containing, or other groups, from one compound (generally regarded as the donor) to another compound (generally regarded as the acceptor). Transferase is the systematic name for any enzyme of EC class 2.</Detail>
      <Keyword>Transferase activity</Keyword>
      <Ontology_ID>GO:0016740</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule.</Detail>
      <Keyword>Kinase activity</Keyword>
      <Ontology_ID>GO:0016301</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.</Detail>
      <Keyword>ATP binding</Keyword>
      <Ontology_ID>GO:0005524</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.</Detail>
      <Keyword>Protein serine/threonine kinase activity</Keyword>
      <Ontology_ID>GO:0004674</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>72</Position>
      <Original>Ile</Original>
      <Variation>Thr</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of mRNA splicing via a spliceosomal mechanism.</Detail>
      <Keyword>Regulation of nuclear mRNA splicing, via spliceosome</Keyword>
      <Ontology_ID>GO:0048024</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A series of reactions that occur within the cell, mediated by protein kinases, which occurs as a result of a single trigger reaction or compound.</Detail>
      <Keyword>Intracellular protein kinase cascade</Keyword>
      <Ontology_ID>GO:0007243</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens.</Detail>
      <Keyword>Innate immune response</Keyword>
      <Ontology_ID>GO:0045087</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process in which an organism has an effect on an organism of a different species.</Detail>
      <Keyword>Interspecies interaction between organisms</Keyword>
      <Ontology_ID>GO:0044419</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The progressive compaction of the spermatid chromatin so that it reaches a level of condensation that is not compatible with nuclear activities such as transcription or DNA replication.</Detail>
      <Keyword>Sperm chromatin condensation</Keyword>
      <Ontology_ID>GO:0035092</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process of removing sections of the primary RNA transcript to remove sequences not present in the mature form of the RNA and joining the remaining sections to form the mature form of the RNA.</Detail>
      <Keyword>RNA splicing</Keyword>
      <Ontology_ID>GO:0008380</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process in which relatively unspecialized cells, e.g. embryonic or regenerative cells, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state.</Detail>
      <Keyword>Cell differentiation</Keyword>
      <Ontology_ID>GO:0030154</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process involved in the conversion of a primary mRNA transcript into one or more mature mRNA(s) prior to translation into polypeptide.</Detail>
      <Keyword>MRNA processing</Keyword>
      <Ontology_ID>GO:0006397</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of viral genome replication.</Detail>
      <Keyword>Negative regulation of viral genome replication</Keyword>
      <Ontology_ID>GO:0045071</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process in which genetic material, in the form of chromosomes, is organized into specific structures and then physically separated and apportioned to two or more sets. In eukaryotes, chromosome segregation begins with the alignment of chromosomes at the metaphase plate, includes chromosome separation, and ends when chromosomes have completed movement to the spindle poles.</Detail>
      <Keyword>Chromosome segregation</Keyword>
      <Ontology_ID>GO:0007059</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of viral genome replication.</Detail>
      <Keyword>Positive regulation of viral genome replication</Keyword>
      <Ontology_ID>GO:0045070</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>311</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>555</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>51</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>309</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>37</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>585</Position>
      <PTM_Type>N6-acetyllysine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MERKVLALQARKKRTKAKKDKAQRKSETQHRGSAPHSESDLPEQEEEILGSDDDEQEDPNDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPQPKPADKMSKNKKKKLKKKQKRQAELLEKRMQEIEEMEKESGPGQKRPNKQEESESPVERPLKENPPNKMTQEKLEESSTIGQDQTLMERDTEGGAAEINCNGVIEVINYTQNSNNETLRHKEDLHNANDCDVQNLNQESSFLSSQNGDSSTSQETDSCTPITSEVSDTMVCQSSSTVGQSFSEQHISQLQESIRAEIPCEDEQEQEHNGPLDNKGKSTAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS</Protein_Seq>
    <DNA_Seq>GGTCTCACCATGGAGCGGAAAGGTGAGCGGTGGAGCGGCCTCCGCCACGAGGGGCAATGGTCGCCGGGGCGAGGCCCGGGTCAGCGCCGGGAGCTTCGCTTAACTGCCGCGGTTCGGTTCCCGGACGTGCGGCGCCCCTCCACTGAGGTGGCGCCGCCCCACACCCCCTGCCTCTGGGCTGCGGGTCCGCGCCCCTCATTCCGGGCGTCCTCTGGCGCCGGCCGTAGCCGCCCCTTGTTCCCCGCCAGGCCGGCTCGCGCCTTGGGGCCACTCCAGGGCCCGGCCCTTGGCGGGCGACGCAGACCCCCACCCGCCCGCCCCCTGACCCGGCCTGAGACCCCTCCGGCGCATCCCGCCCGGGCGCTGCTCTGCGCCCCGTGGGCCGCCAGCCCCACGCCGGCCGCCTCGCCGAGCCCGCAGCCGCCCCCGAGGCAGGCCCCGCAGCCGGGCCTGGCGCCCCTGCTGGGTCTCCACCCTCACCTTGGTCGCCTCCTTTCCTCCACATTCGCCCTTCATCCATCCCTCTCTCCTGCAGTGCTTGCGCTCCAGGCCCGAAAGAAAAGGACCAAGGCCAAGAAGGACAAAGCCCAAAGGAAATCTGAAACTCAGCACCGAGGCTCTGCTCCCCACTCTGAGAGTGATCTACCAGAGCAGGAAGAGGAGATTCTGGGATCTGATGATGATGAGCAAGAAGATCCTAATGATTATTGTAAAGGAGGTTATCATCTTGTGAAAATTGGAGATCTATTCAATGGGAGATACCATGTGATCCGAAAGTTAGGCTGGGGACACTTTTCAACAGTATGGTTATCATGGGATATTCAGGGGAAGAAATTTGTGGCAATGAAAGTAGTTAAAAGTGCTGAACATTACACTGAAACAGCACTAGATGAAATCCGGTTGCTGAAGTCAGTTCGCAATTCAGACCCTAATGATCCAAATAGAGAAATGGTTGTTCAACTACTAGATGACTTTAAAATATCAGGAGTTAATGGAACACATATCTGCATGGTATTTGAAGTTTTGGGGCATCATCTGCTCAAGTGGATCATCAAATCCAATTATCAGGGGCTTCCACTGCCTTGTGTCAAAAAAATTATTCAGCAAGTGTTACAGGGTCTTGATTATTTACATACCAAGTGCCGTATCATCCACACTGACATTAAACCAGAGAACATCTTATTGTCAGTGAATGAGCAGTACATTCGGAGGCTGGCTGCAGAAGCAACAGAATGGCAGCGATCTGGAGCTCCTCCGCCTTCCGGATCTGCAGTCAGTACTGCTCCCCAGCCTAAACCAGCTGACAAAATGTCAAAGAATAAGAAGAAGAAATTGAAGAAGAAGCAGAAGCGCCAGGCAGAATTACTAGAGAAGCGAATGCAGGAAATTGAGGAAATGGAGAAAGAGTCGGGCCCTGGGCAAAAAAGACCAAACAAGCAAGAAGAATCAGAGAGTCCTGTTGAAAGACCCTTGAAAGAGAACCCACCTAATAAAATGACCCAAGAAAAACTTGAAGAGTCAAGTACCATTGGCCAGGATCAAACGCTTATGGAACGTGATACAGAGGGTGGTGCAGCAGAAATTAATTGCAATGGAGTGATTGAAGTCATTAATTATACTCAGAACAGTAATAATGAAACATTGAGACATAAAGAGGATCTACATAATGCTAATGACTGTGATGTCCAAAATTTGAATCAGGAATCTAGTTTCCTAAGTCTCCCAAATGGAGACAGCAGCACATCTCAAGAAACAGACTCTTGTACACCTATAACATCTGAGGTGTCAGACACCATGGTGTGCCAGTCTTCCTCAACTGTAGGTCAGTCATTCAGTGAACAACACATTAGCCAACTTCAAGAAAGCATTCGGGCAGAGATACCCTGTGAAGATGAACAAGAGCAAGAACATAACGGACCACTGGACAACAAAGGAAAATCCACGGCTGGAAATTTTCTTGTTAATCCCCTTGAGCCAAAAAATGCAGAAAAGCTCAAGGTGAAGATTGCTGACCTTGGAAATGCTTGTTGGGTGCACAAACATTTCACTGAAGATATTCAAACAAGGCAATATCGTTCCTTGGAAGTTCTAATCGGATCTGGCTATAATACCCCTGCTGACATTTGGAGCACGGCATGCATGGCCTTTGAACTGGCCACAGGTGACTATTTGTTTGAACCTCATTCAGGGGAAGAGTACACTCGAGATGAAGATCACATTGCATTGATCATAGAACTTCTGGGGAAGGTGCCTCGCAAGCTCATTGTGGCAGGAAAATATTCCAAGGAATTTTTCACCAAAAAAGGTGACCTGAAACATATCACGAAGCTGAAACCTTGGGGCCTTTTTGAGGTTCTAGTGGAGAAGTATGAGTGGTCTCAGGAAGAGGCAGCTGGCTTCACAGATTTCTTACTGCCCATGTTGGAGCTGATCCCTGAGAAGAGAGCCACTGCCGCCGAGTGTCTCCGGCACCCTTGGCTTAACTCCTAAGCCCCTGCCCAGCACCACAGCAGAGATCACACACTGACCCTCCGCCCTTCCCCTTCAAGCATTTTCCTCTTCCCTTTTCAGGGTGAAGCTCTTCCTTCAAGAGTTTCTAGATCTTGTTTTTTTTTTAATCCAACATGTTCATTTGGGTTTGCTTACTTGACCCTGTGGAGATCCCCACAGCCATTGGGCATCCTAGGTGAATTTGGCCTTGGTTGGCTCTGCCAAAGACTAATGGACTAAAATGTGAAACAGCCTCTTGCCCTGTACCTTTCCTTCCCATTAGGACATCCTTTAAATTATAAGCATCCTTTTTGAAAAGAGCTATGAAGGTGTATGAGCCCATCCTTTTATTCATTGACTCTAAGAGTCAAATTTTCTAGTGCATATCCTATTGCCAGCATAAGGATGAGGAGGGGGAAAGGGTCTTAATTCTATGTACAGCAGAGACATTAAACTTGCTGTGTCCGGGCTGCATCATCTTCCTGGACTGTTTCTGTTGTTCTCTGTGTTCACATTTTTTCCTGCAACTTTTAAGCTACTGTCTTTTTTAAATAGCTATATGAACACCAAATTTGGGTACCATTTTATCACTGTTCAAAGCACTGTCAAATTCCTTTCATCCTTTAATAGTTAAGATCTTTGAATCTTCAGTCTGATTTTTAATGTAAGCAAAAACAGAACCATTGAATAGTAATTTCTTGAGAACCTCAGGTGTTCTATAAACAGTCCTTTCCTGTATGTCTTCTATTACCCTAAGACCAGAGTTATTTTGGTTGGTTGTTTTGTTTTATTTTTTGTTTTTGTATCCATGGCTGGCACTTTACTCATTGCACTTGAGTTTATTGCCCCATAACTAAAGGATCAGGATGATGGTAGAACGGAGATCTGGGTTTCAGAGCTTTCCCATTTAAGAAAAATAGATCTTGAGATTCTGATTCTTTTCCAAACAGTCCCCTGCTTTCATGTACAGCTTTTTCTTTACCTTACCCAAAATTCTGGCCTTGAAGCAGTTTTCCTCTATGGCTTTGCTTTCTGATTTTCTCAGAGGCTCGAGTCTTTAATATAACCCCAAATGAAAGAACCAAGGGGAGGGGTGGGATGGCACTTTTTTTTGTTGGTCTTGTTTTGTTTTGTTTTTTGGTTGGTTGGTTATTTTTTAAGATTAGCCATTCTCTGCTGCTATTTCCCTACATAATGTCAATTTTTAACCATAATTTTGACATGATTGAGATGTACTTGAGGCTTTTTTGTTTTAATTGAGAAAAGACTTTGCAATTTTTTTTTAGGATGAGCCTCTCCTAGACTTGACCTAGAATATTACATATTCCTCCAGTAATACTGAAGAGCAAAAGAGAGGCAGGATTGGGGTCACAGCCGCTTCTTCAGCATGGACCAAGTGGGCCTTGGGGATTGCAGCGTTCTCGAAGTGGCTGTAGGACTCGAATTTACAGAAAGCCACAGAGGTGCAACTTGAGGCTCTGCTAGCAAGCCACCAGTGAGGCTATTGGGTAACCACCTTTCTATACAGGAGATTGGAATCTACTTTGTCATTTATCCACCACAGTGACAAAGGAAAAGTGGTGCCGTTATGCAATCCATTTAACTCATAAACATATTACTCTGAGTAACTGGCCAGCCATTCATCGGATCCTTCATTGGGTACTCCTGAAATCAGACATGTTCCTGTAGAAAGAATTTTAAGTTAGGCTTTCTATGCACCTATCAAGAATCAAGAGAATAGATTGTATCAAACAACGGCAGGGAAATCCTTCAGCAATTCTAATCCACTTTGGGTTTTCAGCTGTTTTTACATCTAAAGCAATAGACTAGAACTGAATTATCTTCTACATAGTAAAATCACAATTGTGGAATTCTGGTGATATTAAGGTGAAATAACAAAACACAAAAGGCCCTATTTTAACAGTTGATGTGACAGTAAGTTTTAATAGAACCTGTAACTTCATTTTGGAAATGCTTCTCCACCAAATAAGGGCTTTTTCCCCTATTTAAGGAGCCAGATGGATTGAAAGATGTGGAAATAGGCAGCTGTAGATCTTGATCTTCCAGGTACCCCATGTACCTTTATTGAGCTTAATTATAATACTGTCAAATTGCCACGATCTCACTAAAGGATTTCTATTTGCTGTCAGTTAAAAATAAAGCCCTAAATACATTTTTATTCTTTCTACTGAGGGCATTGTCTGTTTTCTTTGTAAATGCCGTACAATAAACAAATTATTTAATAACCTAAAAAAAAAAAAAAAAAAAAA</DNA_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>Testis</TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Nucleus</CellLocal>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoplasm</CellLocal>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>SRPK1</Gene_Name>
    <Gene_ID>6732</Gene_ID>
    <Genbank_ACCN>NM_003137</Genbank_ACCN>
    <Protein_ACCN>NP_003128</Protein_ACCN>
    <HGNC_ID>11305</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/6732</Gene_URL>
    <UCSC_ID>uc003olh.3</UCSC_ID>
    <EMBL_ID>ENSG00000096063</EMBL_ID>
  </Gene>
  <PPI_List>
    <PPI>
      <Uniprot_ID>Q07955</Uniprot_ID>
      <Gene_Name>SRSF1</Gene_Name>
      <EBI_ID>EBI-398920</EBI_ID>
      <PPI_EBI_URL>EBI-539478,EBI-398920</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>O88453</Uniprot_ID>
      <Gene_Name>Safb</Gene_Name>
      <EBI_ID>EBI-539530</EBI_ID>
      <PPI_EBI_URL>EBI-539478,EBI-539530</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
  </PPI_List>
  <PDB_List>
    <PDB>
      <PDB_Title>Crystal structure of SR protein kinase 1 complexed to its substrate ASF/SF2</PDB_Title>
      <PDB_ID>3BEG</PDB_ID>
      <Resolution>2.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=3BEG</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>ALANINE $ PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER $ PHOSPHOSERINE</Ligand_Name>
      <PubMed_Title>A sliding docking interaction is essential for sequential and processive phosphorylation of an SR protein by SRPK1.</PubMed_Title>
      <Author>Ngo JC, et.al.</Author>
      <Journal>Mol Cell. 2008 Mar 14;29(5):563-76.</Journal>
      <PubMed_ID>18342604</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>X-RAY STRUCTURE OF SRPK1</PDB_Title>
      <PDB_ID>1WAK</PDB_ID>
      <Resolution>1.73</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=1WAK</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>1,2-ETHANEDIOL</Ligand_Name>
      <PubMed_Title>SR protein kinase 1 is resilient to inactivation.</PubMed_Title>
      <Author>Ngo JC, et.al.</Author>
      <Journal>Structure. 2007 Jan;15(1):123-33.</Journal>
      <PubMed_ID>17223538</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>SRPK1 BOUND TO 9MER DOCKING MOTIF PEPTIDE</PDB_Title>
      <PDB_ID>1WBP</PDB_ID>
      <Resolution>2.4</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=1WBP</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>ACETATE ION $ ADENOSINE-5'-DIPHOSPHATE</Ligand_Name>
      <PubMed_Title>Interplay between SRPK and Clk/Sty kinases in phosphorylation of the splicing factor ASF/SF2 is regulated by a docking motif in ASF/SF2.</PubMed_Title>
      <Author>Ngo JC, et.al.</Author>
      <Journal>Mol Cell. 2005 Oct 7;20(1):77-89.</Journal>
      <PubMed_ID>16209947</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko05168</Pathway_ID>
      <Pathway_Title>Herpes simplex infection</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
  </Network_List>
  <Fold>
    <CATH_Class>Mixed alpha-beta</CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/1wbp</CATH_URL>
  </Fold>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Detail>domain,N-terminal half of the RS1 motif</Site_Detail>
      <Site_Reference>Huynh N, et al. Biochemistry. 2009,48(48):11432-11440.</Site_Reference>
      <Site_Type>Protein-induced</Site_Type>
      <PubMed_ID>19886675</PubMed_ID>
    </AllostericSite>
  </AllostericSite_List>
  <Enzyme_Nomenclature_List>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID>2.7.11.1</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC2/7/11/1.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
  </Enzyme_Nomenclature_List>
  <Create_Date>2012-05-31</Create_Date>
</Organism_Record>